Bard Associates’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
8,034
+270
+3% +$12.8K 0.11% 94
2026
Q1
$269K Hold
7,764
0.07% 118
2025
Q4
$442K Buy
7,764
+34
+0.4% +$1.84K 0.11% 99
2025
Q3
$404K Buy
7,730
+50
+0.7% +$2.37K 0.11% 124
2025
Q2
$378K Sell
7,680
-1,142
-13% -$49.8K 0.12% 129
2025
Q1
$332K Buy
8,822
+554
+7% +$20.9K 0.12% 134
2024
Q4
$299K Buy
+8,268
New +$275K 0.1% 140

Other funds holding RDVT

Bard Associates's RDVT Position: Q2 2026 in Review

Bard Associates increased its Red Violet (RDVT) stake by 3.5% in Q2 2026, buying an estimated $12.8K and bringing the position to 8,034 shares worth $512K. The position accounts for 0.11% of the portfolio, ranked #94.

Bard Associates first reported a position in RDVT in Q4 2024 and has held it in 7 quarters since. 173 funds tracked by Wall St. Rank hold RDVT as of Q2 2026.

  • Bard Associates held 8,034 shares of Red Violet worth $512K as of Q2 2026.
  • Bard Associates bought 270 Red Violet shares in Q2 2026, an estimated $12.8K.
  • Red Violet made up 0.11% of Bard Associates's portfolio in Q2 2026, its #94 holding.
  • Bard Associates first reported a position in Red Violet in Q4 2024 and has held it in 7 quarters since.
  • 173 funds tracked by Wall St. Rank held Red Violet as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.